OR11-6 Long-term mortality in patients with isolated GHD, ISS, and SGA treated with recombinant GH during childhood in Sweden: Application of a mortality model developed from the general population

K. Albertsson Wikland, L. Sävendahl, A. Märtensson, B. Borgström, A. Niklasson, N.G. Pehrson, P. Bang, J. Dahlgren, J. Gustafson, L. Hagenäs, B. Kriström, S. Norgren, A. Odén
  • Growth Hormone & IGF Research, October 2012, Elsevier
  • DOI: 10.1016/s1096-6374(12)60081-1

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Professor Lars Sävendahl